New Zealand markets closed

Medifast, Inc. (MED)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
26.76+0.83 (+3.20%)
At close: 03:59PM EDT
26.69 -0.07 (-0.26%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 283.60M
Enterprise value 147.74M
Trailing P/E 4.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.32
Price/book (mrq)1.34
Enterprise value/revenue 0.16
Enterprise value/EBITDA 1.57

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-71.50%
S&P500 52-week change 322.43%
52-week high 3109.52
52-week low 325.36
50-day moving average 335.27
200-day moving average 363.42

Share statistics

Avg vol (3-month) 3439.87k
Avg vol (10-day) 3588.01k
Shares outstanding 510.94M
Implied shares outstanding 610.94M
Float 89.71M
% held by insiders 12.69%
% held by institutions 196.39%
Shares short (15 Apr 2024) 42.99M
Short ratio (15 Apr 2024) 46.79
Short % of float (15 Apr 2024) 441.43%
Short % of shares outstanding (15 Apr 2024) 427.33%
Shares short (prior month 15 Mar 2024) 42.05M

Dividends & splits

Forward annual dividend rate 46.6
Forward annual dividend yield 425.45%
Trailing annual dividend rate 33.30
Trailing annual dividend yield 312.73%
5-year average dividend yield 44.78
Payout ratio 453.31%
Dividend date 307 Nov 2023
Ex-dividend date 418 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.55%
Operating margin (ttm)5.29%

Management effectiveness

Return on assets (ttm)16.44%
Return on equity (ttm)35.49%

Income statement

Revenue (ttm)897.81M
Revenue per share (ttm)82.40
Quarterly revenue growth (yoy)-49.90%
Gross profit (ttm)N/A
EBITDA 95.53M
Net income avi to common (ttm)67.76M
Diluted EPS (ttm)6.19
Quarterly earnings growth (yoy)-79.20%

Balance sheet

Total cash (mrq)156.43M
Total cash per share (mrq)14.63
Total debt (mrq)20.57M
Total debt/equity (mrq)9.75%
Current ratio (mrq)2.85
Book value per share (mrq)19.73

Cash flow statement

Operating cash flow (ttm)90.88M
Levered free cash flow (ttm)56.58M